CD86 (B7-2)
CD86 is one of the two B7 molecules on antigen-presenting cells that either wake a T cell up (through CD28) or calm it down (through CTLA-4). Ipilimumab works by stopping CTLA-4 from hogging CD86 and CD80.
Overview
CD86 (chromosome 3q13.33) is a costimulatory molecule of the immunoglobulin superfamily on the surface of antigen-presenting cells that acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T cells by binding the constitutively expressed CD28 receptor (UniProt P42081). CTLA-4 binds CD80 and CD86 with considerably stronger affinity than CD28 does and acts as a decoy receptor (UniProt P16410), which is the interaction anti-CTLA-4 antibodies release.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · CD86 is one of the two B7 molecules on antigen-presenting cells that either wake a T cell up (through CD28) or calm it down (through CTLA-4). Ipilimumab works by stopping CTLA-4 from hogging CD86 and CD80.
- 1 · What it is
CD86 is one of the two B7 molecules on antigen-presenting cells that either wake a T cell up (through CD28) or calm it down (through CTLA-4). Ipilimumab works by stopping CTLA-4 from hogging CD86 and CD80.
- 2 · What goes wrong in cancer
Shares the CD28/CTLA-4 ligand role with CD80; no drug in the corpus binds CD86 directly.
- 3 · How drugs use it
No product in this corpus aims at CD86 (B7-2) yet. Checkpoint drugs are antibodies that cover one side of an immune ‘stand down’ handshake so T cells stay active.
External identifiers
Sources: HGNC HGNC:1705 (approved symbol, name, aliases and cross-references); UniProt P42081 (protein name, function and tissue specificity)
Biology
Shares the CD28/CTLA-4 ligand role with CD80; no drug in the corpus binds CD86 directly.
- Antigen-presenting cells (UniProt P42081)
Notes
top- Prevalence not recorded: HGNC and UniProt carry no positivity rates.
Latest papers
topQuery for this target: (TITLE:"CD86" OR ABSTRACT:"CD86" OR TITLE:"B7-2" OR ABSTRACT:"B7-2" OR TITLE:"B7.2" OR ABSTRACT:"B7.2" OR TITLE:"CD28LG2" OR ABSTRACT:"CD28LG2" OR TITLE:"CD86 molecule" OR ABSTRACT:"CD86 molecule") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about CD86 (B7-2), not a curated reading list.
Similar pages
not linked directly; found by shared links- TargetHHLA2 (B7-H7)
Shares CD28, The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetCD40
Shares CD28, The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetTDO2
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetLILRB1 (ILT2)
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetCD39 (ENTPD1)
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetGITR (TNFRSF18)
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetAdenosine A2A receptor (ADORA2A)
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.
- TargetCD27
Shares The cancer-immunity cycle, Checkpoint (two meanings) and the tag checkpoint-map.